New medicines target an aging yet increasingly well-off country
Category: russellflanneryblog
China Regulator Accepts Akeso, Sino Biopharm Application For Cancer Drug
China is one of the world’s largest markets for cancer treatment
Individuals, Not “Fairy Dust,” May Offer Best Hope For U.S.-China Ties — Kevin Rudd
Cancer will kill more people around the world this year than COVID-19
V Star’s Bruce Yu Finds Homegrown Success In China Venture Capital
V Star’s Bruce Yu earlier in his career worked alongside Forbes Midas List members Jenny Lee and Jinxiu Foo.
Cancer Drug Prospects Help Celgene-Backed Antengene Gain In Hong Kong Debut
China’s influence in the global pharmaceutical industry is on the rise
Biortus Gets $15 Mln From Pharmaron-Backed Bayland Capital
The COVID-19 pandemic has put a spotlight on China’s pharmaceutical industry.
China Drug Maker’s Shares Plunge On AstraZeneca Vaccine “Pause”
AstraZeneca has been considered to be a global leader in the race to develop a COVID-19 vaccine.
Cancer Fight Shows Way For U.S., China To Cool Off, Collaborate: Kevin Rudd
The U.S. and China should look to their success in the fight against cancer as a way forward in their relations, the former Australia prime minister suggests.
Memorial Sloan Kettering, Genentech, Jiahui Health To Join Forbes China Health Summit On Aug. 15
Approximately three million people will die from cancer in China this year alone
China Cancer Diagnostics Firm Genetron’s Revenue Gains After IPO
China accounts for more than 26% of the world’s cancer deaths.
